New World Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,136
Closed -$254K 82
2024
Q3
$254K Sell
2,136
-112
-5% -$14.9K 0.07% 63
2024
Q2
$321K Sell
2,248
-9
-0.4% -$1.19K 0.09% 47
2024
Q1
$290K Sell
2,257
-20
-0.9% -$2.38K 0.08% 55
2023
Q4
$236K Buy
+2,277
New +$225K 0.07% 62

Other funds holding NVO

New World Advisors's NVO Position: Q4 2024 in Review

New World Advisors sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,136 shares — an estimated $254K sold.

New World Advisors first reported a position in NVO in Q4 2023 and held it in 4 quarters. The position peaked at $321K in Q2 2024. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • New World Advisors reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • New World Advisors sold 2,136 Novo Nordisk shares in Q4 2024, an estimated $254K.
  • New World Advisors first reported a position in Novo Nordisk in Q4 2023 and held it in 4 quarters.
  • New World Advisors's Novo Nordisk position peaked at $321K in Q2 2024.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on New World Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.